Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Hepatoblastoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Radiosurgery 28Magnetic Resonance Spectroscopy 27Dexmedetomidine 8Radiotherapy 7Radiation 7Proton Therapy 7Mental Status and Dementia Tests 7Magnetic Resonance Imaging 7Exercise 6Surgical Procedures, Operative 5Specimen Handling 5Saline Solution 5Blood Specimen Collection 5Bevacizumab 5Remifentanil 4Radiotherapy, Intensity-Modulated 4Propofol 4alovudine 3Transcranial Magnetic Stimulation 3Temozolomide 3Resistance Training 3Methods 3Mannitol 3Diffusion Tensor Imaging 3Cognitive Training 3gadobutrol 2gadobenic acid 2Yoga 2Vitamin D 2Ultrasonography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Brain Neoplasms × Ursodeoxycholic Acid × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡